157 related articles for article (PubMed ID: 1976709)
1. Immunologic responsiveness in American cutaneous leishmaniasis lesions.
Pirmez C; Cooper C; Paes-Oliveira M; Schubach A; Torigian VK; Modlin RL
J Immunol; 1990 Nov; 145(9):3100-4. PubMed ID: 1976709
[TBL] [Abstract][Full Text] [Related]
2. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
3. [Immunopathology of American tegumentary leishmaniasis].
Castés M; Tapia FJ
Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
[TBL] [Abstract][Full Text] [Related]
4. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires.
Uyemura K; Pirmez C; Sieling PA; Kiene K; Paes-Oliveira M; Modlin RL
J Immunol; 1993 Dec; 151(12):7095-104. PubMed ID: 7903101
[TBL] [Abstract][Full Text] [Related]
5. The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production.
Tapia FJ; Caceres-Dittmar G; Sanchez MA; Fernandez AE; Convit J
Biol Res; 1993; 26(1-2):239-47. PubMed ID: 7545501
[TBL] [Abstract][Full Text] [Related]
6. Cell mediated immunity in American cutaneous and mucosal leishmaniasis.
Carvalho EM; Johnson WD; Barreto E; Marsden PD; Costa JL; Reed S; Rocha H
J Immunol; 1985 Dec; 135(6):4144-8. PubMed ID: 4067312
[TBL] [Abstract][Full Text] [Related]
7. Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis.
Conceição-Silva F; Dórea RC; Pirmez C; Schubach A; Coutinho SG
Clin Exp Immunol; 1990 Feb; 79(2):221-6. PubMed ID: 2311299
[TBL] [Abstract][Full Text] [Related]
8. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis.
Rocha PN; Almeida RP; Bacellar O; de Jesus AR; Filho DC; Filho AC; Barral A; Coffman RL; Carvalho EM
J Infect Dis; 1999 Nov; 180(5):1731-4. PubMed ID: 10515843
[TBL] [Abstract][Full Text] [Related]
10. Antigen-reactive gamma delta T cells in human leishmaniasis.
Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG
J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802
[TBL] [Abstract][Full Text] [Related]
11. Immunological selection for Leishmania (Viannia) braziliensis antigens.
Cuba Cuba CA; Ogunkolade W; Howard MK; Miles MA
Ann Trop Med Parasitol; 2001 Jul; 95(5):473-83. PubMed ID: 11487369
[TBL] [Abstract][Full Text] [Related]
12. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway.
Shin HC; Benbernou N; Esnault S; Guenounou M
Cytokine; 1999 Apr; 11(4):257-66. PubMed ID: 10328864
[TBL] [Abstract][Full Text] [Related]
13. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis.
Saravia NG; Valderrama L; Labrada M; Holguín AF; Navas C; Palma G; Weigle KA
J Infect Dis; 1989 Apr; 159(4):725-35. PubMed ID: 2647862
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.
Castés M; Agnelli A; Rondón AJ
Clin Exp Immunol; 1984 Aug; 57(2):279-86. PubMed ID: 6467674
[TBL] [Abstract][Full Text] [Related]
15. Immunopathology of American cutaneous leishmaniasis.
Pirmez C
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():105-9. PubMed ID: 1342704
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific immunodeficiency and its relation to the spectrum of American cutaneous leishmaniasis.
Convit J; Ulrich M
Biol Res; 1993; 26(1-2):159-66. PubMed ID: 7545499
[TBL] [Abstract][Full Text] [Related]
17. Quantification of Leishmania-specific T cells in human American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) by limiting dilution analysis.
Dórea RC; Coutinho SG; Sabroza PC; Hendriks J; Cysne L; Conceição-Silva F
Clin Exp Immunol; 1988 Jan; 71(1):26-31. PubMed ID: 3258203
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
Valli LC; Passos VM; Dietze R; Callahan HL; Berman JD; Grogl M
J Parasitol; 1999 Dec; 85(6):1076-83. PubMed ID: 10647040
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
Titus RG; Lima GC; Engers HD; Louis JA
J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
[TBL] [Abstract][Full Text] [Related]
20. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
Bergmann ES; Ballou RW; Krzych U
Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
